
Kurt Bramer from Advanced CPR Solutions comes back on the show this week to continue the series on Head-Up CPR and other promising sudden cardiac arrest treatments. He and Dr. Joe Holley kicked off the discussion in a previous episode.
Elevated CPR Series Episode One
Elevated CPR Series Episode Three
Elevated CPR Series Episode Four
Elevated CPR Series Episode Five
In this second episode installment of the sudden cardiac arrest and CPR series Kurt and Dr. Joe Holley discuss some key flaws in approaching cardiac arrest research like other medical diseases and treatments. The large number of unknown and uncontrollable variables surrounding sudden cardiac arrest make it hard for randomized control trials to effectively pinpoint positive treatment modalities.
CARES Registry for Cardiac Arrest Stats
Follow up on more of these segments as we continue to look at the current research trends in future episodes and what is on the horizon for the future.
The episode was co-hosted by Sam Bradley and Jamie Davis.
Scroll down for Podcast Discussion Summary
Thank you as always to Paragon Medical Education Group for their long-term support of the Disaster Podcast. Dr. Joe Holley and the team at Paragon continue to provide excellent and customized disaster response training to jurisdictions around the U.S. and internationally as well.
Podcast Discussion Summary
Kurt discussed the paradox between resuscitation research and orphan drugs, highlighting how both lack funding despite their importance. He explained that orphan drugs target rare conditions, making research and development challenging due to limited market potential, similar to the situation in cardiac arrest resuscitation, which is a leading cause of death worldwide but receives limited research funding.
Joe agreed, noting that complacency and insufficient focus contribute to the lack of high-quality research and